151 related articles for article (PubMed ID: 1971778)
1. Effect of dopamine and a dopamine D-1 receptor agonist on pulsatile thyrotrophin secretion in normal women.
Boesgaard S; Hagen C; Hangaard J; Andersen AN; Eldrup E
Clin Endocrinol (Oxf); 1990 Apr; 32(4):423-31. PubMed ID: 1971778
[TBL] [Abstract][Full Text] [Related]
2. Effect of fenoldopam, a dopamine D-1 receptor agonist, on pituitary, gonadal and thyroid hormone secretion.
Boesgaard S; Hagen C; Andersen AN; Eldrup E; Lange P
Clin Endocrinol (Oxf); 1989 Mar; 30(3):231-9. PubMed ID: 2574081
[TBL] [Abstract][Full Text] [Related]
3. Pulsatile gonadotropin secretion and basal prolactin levels during dopamine D-1 receptor stimulation in normal women.
Boesgaard S; Hagen C; Hangaard J; Andersen AN; Eldrup E
Fertil Steril; 1991 Feb; 55(2):281-6. PubMed ID: 1671361
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic inhibition of glycoprotein hormone alpha-subunit in normal subjects.
Boesgaard S; Hagen C; Nyboe Andersen A; Agner T
Metabolism; 1991 Feb; 40(2):150-4. PubMed ID: 1671164
[TBL] [Abstract][Full Text] [Related]
5. Effect of dopamine, dopamine D-1 and D-2 receptor modulation on ACTH and cortisol levels in normal men and women.
Boesgaard S; Hagen C; Andersen AN; Fenger M; Eldrup E
Acta Endocrinol (Copenh); 1990 Jan; 122(1):29-36. PubMed ID: 1968308
[TBL] [Abstract][Full Text] [Related]
6. Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects.
Bughi S; Horton R; Antonipillai I; Manoogian C; Ehrlich L; Nadler J
J Clin Endocrinol Metab; 1989 Dec; 69(6):1116-21. PubMed ID: 2573613
[TBL] [Abstract][Full Text] [Related]
7. Evidence against a role for dopamine D1 receptors in the myocardium of the pig.
Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD
Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206
[TBL] [Abstract][Full Text] [Related]
8. Lack of effect of lithium on the renal response to DA1-dopamine receptor stimulation by fenoldopam in normal man.
Girbes AR; Smit AJ; Meijer S; Reitsma WD
Br J Clin Pharmacol; 1990 Apr; 29(4):413-5. PubMed ID: 1970264
[TBL] [Abstract][Full Text] [Related]
9. Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog.
Clark KL; Hilditch A; Robertson MJ; Drew GM
J Hypertens; 1991 Dec; 9(12):1143-50. PubMed ID: 1685741
[TBL] [Abstract][Full Text] [Related]
10. Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats.
Chen CJ; Apparsundaram S; Lokhandwala MF
J Pharmacol Exp Ther; 1991 Feb; 256(2):486-91. PubMed ID: 1671595
[TBL] [Abstract][Full Text] [Related]
11. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
Hadengue A; Moreau R; Bacq Y; Gaudin C; Braillon A; Lebrec D
Hepatology; 1991 Jan; 13(1):111-6. PubMed ID: 1671029
[TBL] [Abstract][Full Text] [Related]
12. Effects of fenoldopam on alpha-methyl-p-tyrosine-stimulated prolactin secretion in conscious rats.
Schoors DF; Dupont AG
Eur J Pharmacol; 1989 Nov; 173(1):109-12. PubMed ID: 2575038
[TBL] [Abstract][Full Text] [Related]
13. Selective dopamine-1 receptor agonist augments regional myocardial blood flow: comparison of fenoldopam and dopamine.
Shi Y; Zalewski A; Bravette B; Maroko AR; Maroko PR
Am Heart J; 1992 Aug; 124(2):418-23. PubMed ID: 1353297
[TBL] [Abstract][Full Text] [Related]
14. Hypothalamic regulation of pulsatile thyrotopin secretion.
Brabant G; Prank K; Hoang-Vu C; Hesch RD; von zur Mühlen A
J Clin Endocrinol Metab; 1991 Jan; 72(1):145-50. PubMed ID: 1670779
[TBL] [Abstract][Full Text] [Related]
15. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.
Le Monnier de Gouville AC; Lawson K; Thiry C; Cavero I
J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375
[TBL] [Abstract][Full Text] [Related]
16. Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam.
Hedge SS; Ricci A; Amenta F; Lokhandwala MF
J Pharmacol Exp Ther; 1989 Dec; 251(3):1237-45. PubMed ID: 2574743
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the effects of dopamine-1 and dopamine-2 receptor agonists on coronary flow.
Zhao RR; Wang PH; Zhang WF; Fennell WH
Methods Find Exp Clin Pharmacol; 1992; 14(1):5-11. PubMed ID: 1352371
[TBL] [Abstract][Full Text] [Related]
18. Do renal tubular dopamine receptors mediate dopamine-induced diuresis in the anesthetized cat?
Clark KL; Robertson MJ; Drew GM
J Cardiovasc Pharmacol; 1991 Feb; 17(2):267-76. PubMed ID: 1709232
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of dopamine and fenoldopam, a selective dopamine-1 agonist, on parathyroid hormone release in man.
Bakris GL; Weber RR; Nelson K; Elliott WJ; Kaplan E; Murphy MB
Miner Electrolyte Metab; 1988; 14(6):343-6. PubMed ID: 2906737
[TBL] [Abstract][Full Text] [Related]
20. Lithium and the renal response to gludopa, fenoldopam and dopamine.
Girbes AR; Smit AJ; Meijer S; Reitsma WD
Br J Clin Pharmacol; 1990 Oct; 30(4):652-3. PubMed ID: 1981323
[No Abstract] [Full Text] [Related]
[Next] [New Search]
